Update on nonhormonal approaches to menopausal management

Area of Science:

• Reproductive Endocrinology
• Women's Health
• Menopause Management

Background:

• Vasomotor symptoms and other menopause-related issues significantly impact quality of life.
• Hormone therapy (HT) is a primary treatment, but contraindications or patient preference necessitate alternatives.
• Vaginal atrophy requires specific treatment considerations, with local estrogen as an option.

Purpose of the Study:

• To review nonhormonal alternatives to systemic hormone therapy (HT) for managing menopause symptoms.
• To discuss the risk-benefit evaluation for menopause management tailored to individual women.
• To highlight treatment options for women unable or unwilling to use systemic HT.

Main Methods:

• Literature review of nonhormonal treatments for menopausal symptoms.
• Analysis of risk-benefit profiles for various menopause management strategies.
• Evaluation of local vaginal estrogen for vaginal atrophy treatment.

Main Results:

• Individualized assessment of bothersome symptoms and risk tolerance is crucial for effective menopause management.
• Systemic HT is optimal for most symptomatic women, but nonhormonal options are viable alternatives.
• Local vaginal estrogen effectively treats vaginal atrophy in women avoiding systemic HT.

Conclusions:

• Treatment decisions for menopausal symptoms must be personalized, balancing symptom severity, risks, and quality of life.
• A range of nonhormonal therapies, including local vaginal estrogen, effectively addresses menopausal symptoms and bone loss.
• Healthcare providers should offer tailored management plans, considering patient-specific factors and preferences.